List of Tables
Table 1. Global Oral Transmucosal Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oral Transmucosal Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oral Transmucosal Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oral Transmucosal Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oral Transmucosal Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oral Transmucosal Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oral Transmucosal Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oral Transmucosal Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oral Transmucosal Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Transmucosal Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Transmucosal Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Oral Transmucosal Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Transmucosal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Transmucosal Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Transmucosal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oral Transmucosal Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Oral Transmucosal Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Oral Transmucosal Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Oral Transmucosal Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Oral Transmucosal Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oral Transmucosal Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Oral Transmucosal Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oral Transmucosal Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Oral Transmucosal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oral Transmucosal Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Oral Transmucosal Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Oral Transmucosal Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oral Transmucosal Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oral Transmucosal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oral Transmucosal Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oral Transmucosal Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oral Transmucosal Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oral Transmucosal Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oral Transmucosal Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oral Transmucosal Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oral Transmucosal Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oral Transmucosal Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oral Transmucosal Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oral Transmucosal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oral Transmucosal Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oral Transmucosal Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oral Transmucosal Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Transmucosal Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oral Transmucosal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oral Transmucosal Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oral Transmucosal Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oral Transmucosal Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oral Transmucosal Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oral Transmucosal Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Oral Transmucosal Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Oral Transmucosal Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Oral Transmucosal Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Oral Transmucosal Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oral Transmucosal Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oral Transmucosal Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Oral Transmucosal Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Oral Transmucosal Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Oral Transmucosal Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Oral Transmucosal Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Oral Transmucosal Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Oral Transmucosal Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Oral Transmucosal Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Oral Transmucosal Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oral Transmucosal Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oral Transmucosal Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Oral Transmucosal Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Oral Transmucosal Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Oral Transmucosal Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. LTS Lohmann Therapie-Systeme AG Company Information
Table 71. LTS Lohmann Therapie-Systeme AG Description and Business Overview
Table 72. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product
Table 74. LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
Table 75. Soligenix Company Information
Table 76. Soligenix Description and Business Overview
Table 77. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Soligenix Oral Transmucosal Drugs Product
Table 79. Soligenix Recent Developments/Updates
Table 80. ZIM Laboratories Limited Company Information
Table 81. ZIM Laboratories Limited Description and Business Overview
Table 82. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. ZIM Laboratories Limited Oral Transmucosal Drugs Product
Table 84. ZIM Laboratories Limited Recent Developments/Updates
Table 85. Access Pharmaceutical Inc. Company Information
Table 86. Access Pharmaceutical Inc. Description and Business Overview
Table 87. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product
Table 89. Access Pharmaceutical Inc. Recent Developments/Updates
Table 90. C.L Pharm Company Information
Table 91. C.L Pharm Description and Business Overview
Table 92. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. C.L Pharm Oral Transmucosal Drugs Product
Table 94. C.L Pharm Recent Developments/Updates
Table 95. Cure Pharmaceutical Company Information
Table 96. Cure Pharmaceutical Description and Business Overview
Table 97. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Cure Pharmaceutical Oral Transmucosal Drugs Product
Table 99. Cure Pharmaceutical Recent Developments/Updates
Table 100. Aquestive Therapeutics, Inc. Company Information
Table 101. Aquestive Therapeutics, Inc. Description and Business Overview
Table 102. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product
Table 104. Aquestive Therapeutics, Inc. Recent Developments/Updates
Table 105. NAL Pharma Company Information
Table 106. NAL Pharma Description and Business Overview
Table 107. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. NAL Pharma Oral Transmucosal Drugs Product
Table 109. NAL Pharma Recent Developments/Updates
Table 110. IntelGenx Corp. Company Information
Table 111. IntelGenx Corp. Description and Business Overview
Table 112. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. IntelGenx Corp. Oral Transmucosal Drugs Product
Table 114. IntelGenx Corp. Recent Developments/Updates
Table 115. Eisai Co., Ltd. Company Information
Table 116. Eisai Co., Ltd. Description and Business Overview
Table 117. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Eisai Co., Ltd. Oral Transmucosal Drugs Product
Table 119. Eisai Co., Ltd. Recent Developments/Updates
Table 120. Otsuka Pharmaceutical Co., Ltd. Company Information
Table 121. Otsuka Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product
Table 124. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Teva Pharmaceutical Industries Ltd. Company Information
Table 126. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 127. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product
Table 129. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 130. GlaxoSmithKline plc Company Information
Table 131. GlaxoSmithKline plc Description and Business Overview
Table 132. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. GlaxoSmithKline plc Oral Transmucosal Drugs Product
Table 134. GlaxoSmithKline plc Recent Developments/Updates
Table 135. Viatris Company Information
Table 136. Viatris Description and Business Overview
Table 137. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Viatris Oral Transmucosal Drugs Product
Table 139. Viatris Recent Developments/Updates
Table 140. Bristol-Myers Squibb Company Company Information
Table 141. Bristol-Myers Squibb Company Description and Business Overview
Table 142. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product
Table 144. Bristol-Myers Squibb Company Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oral Transmucosal Drugs Distributors List
Table 148. Oral Transmucosal Drugs Customers List
Table 149. Oral Transmucosal Drugs Market Trends
Table 150. Oral Transmucosal Drugs Market Drivers
Table 151. Oral Transmucosal Drugs Market Challenges
Table 152. Oral Transmucosal Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Transmucosal Drugs
Figure 2. Global Oral Transmucosal Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Transmucosal Drugs Market Share by Type: 2024 & 2031
Figure 4. Tablets Product Picture
Figure 5. Films Product Picture
Figure 6. Liquid Spray Product Picture
Figure 7. Gels Product Picture
Figure 8. Others Product Picture
Figure 9. Global Oral Transmucosal Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Oral Transmucosal Drugs Market Share by Application: 2024 & 2031
Figure 11. Cardiovascular Disorders
Figure 12. Acute Pain Managements
Figure 13. Diabetes
Figure 14. Others
Figure 15. Global Oral Transmucosal Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Oral Transmucosal Drugs Market Size (2020-2031) & (US$ Million)
Figure 17. Global Oral Transmucosal Drugs Sales (2020-2031) & (K Units)
Figure 18. Global Oral Transmucosal Drugs Average Price (US$/Unit) & (2020-2031)
Figure 19. Oral Transmucosal Drugs Report Years Considered
Figure 20. Oral Transmucosal Drugs Sales Share by Manufacturers in 2024
Figure 21. Global Oral Transmucosal Drugs Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Oral Transmucosal Drugs Players: Market Share by Revenue in Oral Transmucosal Drugs in 2024
Figure 23. Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Oral Transmucosal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Oral Transmucosal Drugs Sales Market Share by Country (2020-2031)
Figure 26. North America Oral Transmucosal Drugs Revenue Market Share by Country (2020-2031)
Figure 27. United States Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Oral Transmucosal Drugs Sales Market Share by Country (2020-2031)
Figure 30. Europe Oral Transmucosal Drugs Revenue Market Share by Country (2020-2031)
Figure 31. Germany Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Oral Transmucosal Drugs Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Oral Transmucosal Drugs Revenue Market Share by Region (2020-2031)
Figure 38. China Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Oral Transmucosal Drugs Sales Market Share by Country (2020-2031)
Figure 48. Latin America Oral Transmucosal Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Oral Transmucosal Drugs Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Oral Transmucosal Drugs Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Oral Transmucosal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Oral Transmucosal Drugs by Type (2020-2031)
Figure 58. Global Revenue Market Share of Oral Transmucosal Drugs by Type (2020-2031)
Figure 59. Global Oral Transmucosal Drugs Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Sales Market Share of Oral Transmucosal Drugs by Application (2020-2031)
Figure 61. Global Revenue Market Share of Oral Transmucosal Drugs by Application (2020-2031)
Figure 62. Global Oral Transmucosal Drugs Price (US$/Unit) by Application (2020-2031)
Figure 63. Oral Transmucosal Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
